Carregant...
Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
Current vaccines that provide protection against infectious diseases have primarily relied on attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid proteins that can initiate an immune response but do not include the genetic material required for replication, promote...
Guardat en:
| Publicat a: | Wiley Interdiscip Rev Nanomed Nanobiotechnol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169818/ https://ncbi.nlm.nih.gov/pubmed/20872839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.119 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|